D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 39,915 271 World Ranking 7294 National Ranking 3991

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Surgery

Stephen F. Lowry mostly deals with Immunology, Tumor necrosis factor alpha, Internal medicine, Cytokine and Endocrinology. His Tumor necrosis factor alpha research is multidisciplinary, incorporating perspectives in Lipopolysaccharide, Shock, Endogeny, Antibody and Mediator. His Internal medicine study deals with Gastroenterology intersecting with Parenteral Nutrition Solutions.

His Cytokine research is multidisciplinary, incorporating elements of Inflammation, Receptor, Autocrine signalling and Wound healing. His Endocrinology research includes themes of Cachexia and Monokine. His work in Septic shock covers topics such as Bacteremia which are related to areas like Necrosis.

His most cited work include:

  • Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia (2308 citations)
  • Shock and tissue injury induced by recombinant human cachectin. (2296 citations)
  • Genomic responses in mouse models poorly mimic human inflammatory diseases (1987 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Endocrinology, Immunology, Tumor necrosis factor alpha and Cytokine. His Internal medicine study frequently links to related topics such as Gastroenterology. His Endocrinology research incorporates themes from Amino acid and In vivo.

His Immunology research focuses on Sepsis, Inflammation, Immune system, Innate immune system and Pathogenesis. His study in Tumor necrosis factor alpha is interdisciplinary in nature, drawing from both Lipopolysaccharide, Shock, Receptor, Interleukin and Mediator. His studies deal with areas such as Proinflammatory cytokine and Receptor antagonist as well as Cytokine.

He most often published in these fields:

  • Internal medicine (47.29%)
  • Endocrinology (40.36%)
  • Immunology (31.63%)

What were the highlights of his more recent work (between 2007-2015)?

  • Immunology (31.63%)
  • Inflammation (12.65%)
  • Internal medicine (47.29%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, Inflammation, Internal medicine, Heart rate variability and Neuroscience. The various areas that Stephen F. Lowry examines in his Immunology study include Transcriptome and Signal transduction. Stephen F. Lowry has included themes like Receptor, Regulation of gene expression and Sepsis in his Inflammation study.

His studies in Sepsis integrate themes in fields like Bacteremia, Complication, Incidence and Intensive care medicine. His research integrates issues of Score test, Multiple comparisons problem, Endocrinology and Oncology in his study of Internal medicine. Stephen F. Lowry studied Endocrinology and In vivo that intersect with Cytokine and Splanchnic.

Between 2007 and 2015, his most popular works were:

  • Genomic responses in mouse models poorly mimic human inflammatory diseases (1987 citations)
  • A genomic storm in critically injured humans (701 citations)
  • APOε4 is associated with enhanced in vivo innate immune responses in human subjects (87 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Surgery

His primary areas of study are Inflammation, Immunology, Sepsis, Neuroscience and Heart rate variability. His research investigates the connection between Inflammation and topics such as Signal transduction that intersect with problems in Extracellular and Pharmacology. His Immunology study incorporates themes from Regulation of gene expression and Homeostasis.

His Sepsis study is concerned with the field of Surgery as a whole. His Circadian rhythm study combines Internal medicine and Endocrinology studies. His Internal medicine study often links to related topics such as In vivo.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Shock and tissue injury induced by recombinant human cachectin.

Kevin J. Tracey;Bruce A Beutler;Stephen F. Lowry;James Merryweather.
Science (1986)

3274 Citations

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

Kevin J. Tracey;Kevin J. Tracey;Yuman Fong;David G. Hesse;Kirk R. Manogue.
Nature (1987)

3244 Citations

Genomic responses in mouse models poorly mimic human inflammatory diseases

Seok Junhee Seok;Shaw Warren H. Shaw Warren;G. Cuenca Alex;N. Mindrinos Michael.
Proceedings of the National Academy of Sciences of the United States of America (2013)

2457 Citations

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

Charles J. Fisher;Jan M. Agosti;Steven M. Opal;Stephen F. Lowry.
The New England Journal of Medicine (1996)

1807 Citations

A network-based analysis of systemic inflammation in humans

Steve E. Calvano;Wenzhong Xiao;Daniel R. Richards;Ramon M. Felciano.
Nature (2005)

1509 Citations

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

Charles J. Fisher;Jean-Francois A. Dhainaut;Steven M. Opal;John P. Pribble.
JAMA (1994)

1237 Citations

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

Steven M. Opal;Charles J. Fisher;Jean-Francois A. Dhainaut;Jean-Louis Vincent.
Critical Care Medicine (1997)

1045 Citations

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

K J Van Zee;T Kohno;E Fischer;C S Rock.
Proceedings of the National Academy of Sciences of the United States of America (1992)

1016 Citations

A genomic storm in critically injured humans

Wenzhong Xiao;Wenzhong Xiao;Michael N. Mindrinos;Junhee Seok;Joseph Cuschieri.
Journal of Experimental Medicine (2011)

940 Citations

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Y Fong;K J Tracey;L L Moldawer;D G Hesse.
Journal of Experimental Medicine (1989)

862 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen F. Lowry

Lyle L. Moldawer

Lyle L. Moldawer

University of Florida

Publications: 138

Tom van der Poll

Tom van der Poll

University of Amsterdam

Publications: 132

Kevin J. Tracey

Kevin J. Tracey

Feinstein Institute for Medical Research

Publications: 101

Richard D. Smith

Richard D. Smith

Pacific Northwest National Laboratory

Publications: 90

Charles A. Dinarello

Charles A. Dinarello

University of Colorado Denver

Publications: 89

Jean Louis Vincent

Jean Louis Vincent

Université Libre de Bruxelles

Publications: 83

Yoram Vodovotz

Yoram Vodovotz

University of Pittsburgh

Publications: 80

Steven M. Opal

Steven M. Opal

Brown University

Publications: 80

Timothy R. Billiar

Timothy R. Billiar

University of Pittsburgh

Publications: 69

Irshad H. Chaudry

Irshad H. Chaudry

University of Alabama at Birmingham

Publications: 67

Daniel G. Remick

Daniel G. Remick

Boston University

Publications: 67

Hector R. Wong

Hector R. Wong

Cincinnati Children's Hospital Medical Center

Publications: 59

Ronald G. Tompkins

Ronald G. Tompkins

Harvard University

Publications: 55

Haichao Wang

Haichao Wang

Feinstein Institute for Medical Research

Publications: 54

Alfred Ayala

Alfred Ayala

Brown University

Publications: 52

Marcel Levi

Marcel Levi

University College London Hospitals NHS Foundation Trust

Publications: 51

Something went wrong. Please try again later.